Detalhe da pesquisa
1.
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Gynecol Oncol
; 128(2): 327-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219661
2.
Kit gene in endometrial carcinoma: an immunohistochemical and mutational analysis.
Int J Gynecol Cancer
; 21(2): 203-5, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270602
3.
Expression of ERCC1, p53, and class III ß-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study.
Int J Gynecol Cancer
; 21(6): 1071-7, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792013
4.
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.
Clin Cancer Res
; 14(18): 5869-76, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794099